The race for an antibody against the coronavirus
Apoorva Mandavilli, The New York Times
Updated as of Oct 14 12:17 PM
Even as vaccines are hailed as our best hope against the coronavirus, dozens of scientific groups are working on an alternate defense: monoclonal antibodies. These therapies shot to prominence just this month after President Donald Trump got an infusion of an antibody cocktail made by Regeneron and credited it for his apparent recovery, even calling it a “cure.”
Read more »